HRTS

Tema Cardiovascular and Metabolic ETF

Investor Moves

InvestorPortfolio ValuePortfolio ChangePosition ChangeAvg Buy PriceCurrent Price
Ken GriffinCitadel Advisors
$-1.2M
ExitQ2 2025
$1.2M
--
--
Ken GriffinCitadel Advisors
$-1.2M
ExitQ2 2025
$1.2M
--
--
Ken GriffinCitadel Advisors
$-840.7K
ExitQ3 2024
$841k
--
--
Ken GriffinCitadel Advisors
$-840.7K
ExitQ3 2024
$841k
--
--
Ken GriffinCitadel Advisors
$-744.3K
TrimQ2 2024
$744k
--
--

News

zacks.comGLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gainzacks.comMay 19businesswire.comTema ETFs Surpasses $2 Billion in AUM in Under Three Yearsbusinesswire.comApr 16